OR WAIT null SECS
August 13, 2021
Bayer has acquired Vividion Therapeutics, a US-based biopharmaceutical company.
Rentschler Biopharma has broken ground nearby its Milford, Mass., site where it will build its new multi-product manufacturing facility for commercial production of complex molecules.
Lykan Bioscience and Vineti will combine their capabilities to streamline process development and manufacturing to move cell therapies through clinical phases to commercialization.
The President calls for granting Medicare authority to negotiate drug prices and penalties for pharma companies that raise prices faster than inflation.
The agency has amended the emergency use authorizations for the Pfizer-BioNTech and Moderna vaccines to allow certain immunocompromised people to receive an additional dose of the vaccine.
Recro acquires CDMO IRISYS, establishing a bi-coastal presence in the US.
August 12, 2021
A research team at the Keck Graduate Institute will work to adapt its decade-long low-cost vaccine R&D for developing countries into a COVID-19 vaccine.
FDA has awarded Fast Track designation to Vivet Therapeutics’ novel gene therapy, VTX-801.
A collaboration between Aldevron and Ginkgo Bioworks has resulted in a manufacturing enhancement that can improve production of an enzyme used for mRNA therapeutics.
Veraxa and Indivumed will work together to develop colorectal antibody drugs.